11 research outputs found

    Cytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patients

    Get PDF
    BACKGROUND: Undifferentiated Nasopharyngeal Carcinoma (NPC) patients show a characteristic pattern of antibody responses to the Epstein-Barr virus (EBV) which is regularly associated with this tumor. However, no EBV-specific cytotoxic activity is detectable by the standard chromium-release assay at both peripheral and intratumoral levels. The mechanisms underlying this discrepancy between the humoral and cellular immune responses in NPC are still unknown, but might be related to an imbalance in immunoregulatory interleukin production. In this report, we investigated the ability of peripheral (PBL) and tumor- infiltrating (TIL) lymphocytes of undifferentiated NPC patients to produce in vitro three interleukins (IL-2, IL-6, IL-10) and three immunoglobulin isotypes (IgM, IgG, IgA). METHODS: Lymphocytes from 17 patients and 17 controls were cultured in the presence of Pokeweed mitogen (PWM) for 12 days and their culture supernatants were tested for interleukins and immunoglobulins by specific enzyme-linked immunosorbent assays (ELISA). Data were analysed using Student's t-test and probability values below 5% were considered significant. RESULTS: The data obtained indicated that TIL of NPC patients produced significantly more IL-2 (p = 0,0002), IL-10 (p = 0,020), IgM (p= 0,0003) and IgG (p < 0,0001) than their PBL. On the other hand, patients PBL produced significantly higher levels of IL-2 (p = 0,022), IL-10 (p = 0,016) and IgM (p = 0,004) than those of controls. No significant differences for IL-6 and IgA were observed. CONCLUSION: Taken together, our data reinforce the possibility of an imbalance in immunoregulatory interleukin production in NPC patients. An increased ability to produce cytokines such as IL-10 may underlie the discrepancy between humoral and cellular immune responses characteristic of NPC

    Data from: Conservation priorities for endangered coastal North African Pennisetum glaucum L. landrace populations as inferred from phylogenetic considerations and population structure analysis

    No full text
    The increasing anthropologic pressure and the modernization of agriculture have led to a forsaking of pearl millet traditional cultivars inducing a progressive loss of the genetic variability encompassed in this locally-adapted germplasm. Imperatively, national efforts based on robust data gleaned from genetic surveys have to be undertaken in order to set up suitable conservation priorities. Inthis study, in addition to the assessment of the genetic diversity and population structure among and within a set of seven pearl millet landrace populations from coastal North Africa, demographic and phylogenetic data, conservation priority scores were calculated according to Vane-Wright et al. (1991). To date, genetic diversity of pearl millet in North Africa is still poorly documented. The present survey reports for the first time the use of highly informative nSSR markers (PIC =0.74) on P. glaucum landraces representative of the Mediterranean coastline of North Africa. A high level of genetic diversity was obtained within the investigated landraces (He=0.80) at the population level. FST, AFC-3D and Bayesian clustering underlined significant differentiation and an apparent genetic structure according to geographical origin. Phylogenetic considerations integrated with demographic and genetic information enabled conclusive inferences of highly prioritized populations for conservation. Populations Haouaria, Hammem Laghzez, Mahdia and Medenine representatives of the main pearl millet growing areas in Tunisia and cultivated in the North African littoral should be strongly recommended for an ex-situ conservation program. Dynamic on-farm conservation method is also required as it allows to the local landraces to evolve in different environments while maintaining their adaptation potentials

    Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units

    No full text
    International audienc
    corecore